Defunct Company
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
132
NCT03011931
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
Phase: Early Phase 1
Role: Collaborator
Start: Mar 31, 2016
Completion: Feb 28, 2019
NCT03585478
Latiglutenase as a Treatment for Celiac Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 1, 2019
Completion: Jan 22, 2021
NCT04839575
Study of Latiglutenase in T1D/CD Patients
Start: Apr 6, 2021
Completion: Dec 19, 2022